$48 Billion — Our most important show ever
Dumb Money Live
00:00
Is This Drug Really a Double-Action Thing That Will Reduce Weight Loss?
Novo Stock got hit earlier the last year because they had an issue with one of their suppliers who actually makes the injectable syringes That you need for this drug and that set them back like six to nine months in fact. The cost of this drug is Roughly $1,300 a month most people right now are paying that cash out of pocket. People are literally going from pharmacy to pharmacy to pharmacy Trying to get their prescription filled. It's sold out everywhere. But I think we're going to be in this situation where for the next few years They'll barely be able to keep up with demand.
Transcript
Play full episode
